Sensei biotherapeutics named a winner of comparably's best ceo award

Boston, dec. 16, 2021 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), an immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced that it has won a comparably award for 2021 “best ceos.”
SNSE Ratings Summary
SNSE Quant Ranking